Inflammatory protein substrates

Inflammatory protein substrates is a generic and collective term referring to the various proteins that undergo biochemical modification, such as phosphorylation or proteolytic cleavage, during an inflammatory response. This term is frequently encountered in scientific literature describing the downstream effectors of the PIM1 kinase, which phosphorylates substrates like AKT and NF-κB to promote macrophage activation and T-cell differentiation (Yang et al., 2024; Frontiers in Immunology). Additionally, it may encompass substrates of the inflammasome, such as pro-interleukin-1 beta and Gasdermin D, which are processed by caspases to mediate cytokine release and pyroptosis (ScienceDaily, 2018). Because the term describes a functional class of molecules rather than a single specific protein or receptor, it is not considered a canonical therapeutic target in drug discovery. Instead, pharmacological intervention typically focuses on the upstream enzymes (e.g., kinases, proteases) or receptors that act upon these substrates to modulate the inflammatory cascade. Consequently, while these substrates are essential for the pathogenesis of conditions like rheumatoid arthritis and inflammatory bowel disease, they serve as markers of pathway activity rather than direct drug-binding sites.

Other names

Inflammatory substratesDownstream inflammatory signaling targetsPIM1 substratesInflammasome substrates

Not applicable; these molecules are substrates for enzymes (such as kinases or proteases) rather than primary therapeutic targets for drug binding.